Recent Updates
Recently added Catalysts
HAE Positive Sentiment

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference...

Key Takeaway: Haemonetics Corporation announced that its President and CEO, Chris Simon, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 14, 2025. The presentation will be available via live audio webcast, and a replay will be accessible for 30 days afterward. This event highlights Haemonetics' commitment to innovative healthcare solutions.
Price reaction · baseline $80.05 (2025-01-03 close) · 1 other HAE headline(s) in the window, move may be shared
day 0 close · peak
-1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Haemonetics is participating in a prestigious healthcare conference.
  • The presentation will be accessible to the public via a live webcast.
  • The company aims to improve patient care and reduce healthcare costs.

Full Press Release Details

BOSTON , Jan. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that Chris Simon , President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time .
The public may access Mr. Simon's presentation live via audio webcast at:
The live webcast can also be accessed under the Events & Presentations section of Haemonetics' Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Haemonetics' Investor Relations website beginning approximately one hour after completion of the live event.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE ) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com .
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
David Trenk, Manager-Investor Relations
(781) 356-9763
(203) 733-4987
[email protected]
[email protected]
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
[email protected]

Frequently Asked Questions

When will Haemonetics present at the conference?

Haemonetics will present on January 14, 2025, at 5:15 pm Pacific Time.

How can I access the presentation?

The presentation will be available via a live audio webcast.

Where can I find the replay of the presentation?

The replay will be accessible for 30 days on Haemonetics' Investor Relations website.

Who is presenting for Haemonetics?

Chris Simon, the President and CEO, will be presenting.

Last updated: Jan 6, 2025